Description
"EMERGENCY" FLEBOGAMA 5% 10GM VIALS
First action · last action
2012-08-02 · 2012-08-02
Transactions
1
First transaction's obligation
$17,594
Base + all options value (sum of deltas)
$17,594
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797P5159B
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2012-08-02+$17,594= $17,594
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2012-08-02 | +$17,594 | $17,594 | "EMERGENCY" FLEBOGAMA 5% 10GM VIALS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI W1KSV9EFK9H3)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C26120F0167 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS | $14,106 | FY2020 |
| 36C25918F3943 | NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS | $8,747 | FY2018 |
| 36C25918F3932 | NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS | $12,511 | FY2018 |
| 36C25918F1994 | NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS | $5,310 | FY2018 |
| VA26117F2620 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS | $5,710 | FY2017 |
| VA25717J2334 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6505 · DRUGS AND BIOLOGICALS | $105,642 | FY2017 |
Other recipients under 6505 from 546-MIAMI (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA24812P5514 | PROVEN PHARMACEUTICALS LLC | 546-MIAMI | $14,574 | FY2012 |
| VA24812P5013 | NXSTAGE MEDICAL, INC. | 546-MIAMI | $7,600 | FY2012 |
| VA24812P4899 | MCKESSON CORPORATION | 546-MIAMI | $6,967 | FY2012 |
| VA24812P3822 | MCKESSON CORPORATION | 546-MIAMI | $6,967 | FY2012 |
| VA24812P3275 | NXSTAGE MEDICAL, INC. | 546-MIAMI | $9,240 | FY2012 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24812F4842_3600_V797P5159B_3600 · retrieved 2026-09-26.